Stay updated on CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Sign up to get notified when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.

Latest updates to the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new revision entry (v3.3.3) to the Study Record Versions, and removed the HHS Vulnerability Disclosure link as well as the v3.3.2 revision note from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe history now shows a new revision entry v3.3.2 added, and the previous entry v3.2.0 removed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer displays a government funding notice; this is a minor site-wide update that does not affect the study details or record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check62 days agoChange DetectedNew history entries for versions 9 and 10 appear with updated QC notes, while the core study information remains unchanged.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a prominent operating-status notice and updated the version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference12%

- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC
Enter your email address, and we'll notify you when there's something new on the CONTERNO Trial Comparing Pemetrexed+Platinum with Cosibelimab in NSCLC page.